Cala Biosciences upgraded By: MarketMinute.com Stock News February 16, 2018 at 19:15 PM EST Citigroup upgraded Calithera Biosciences Inc. (Nasdaq: CALA) from a Neutral rating to a Buy rating lifting the stock price $1.15 to close at $8.10. Related Stocks: Calithera Biosci Com